Vitamin K antagonist therapy: changes in the treated populations and in management results in Italian anticoagulation clinics compared with those recorded 20 years ago-Reference-Cited by-同舟云学术

Vitamin K antagonist therapy: changes in the treated populations and in management results in Italian anticoagulation clinics compared with those recorded 20 years ago

Published:2017-05-13 Issue:8 Volume:12 Page:1109-1119
ISSN:1828-0447
Container-title:Internal and Emergency Medicine
language:en
Short-container-title:Intern Emerg Med

Author:

Palareti Gualtiero, ,Antonucci Emilia,Migliaccio Ludovica,Erba Nicoletta,Marongiu Francesco,Pengo Vittorio,Poli Daniela,Testa Sophie,Tosetto Alberto,Tripodi Armando,Moia Marco

Publisher

Springer Science and Business Media LLC

Subject

Emergency Medicine,Internal Medicine

Link

http://link.springer.com/article/10.1007/s11739-017-1678-9/fulltext.html

Reference33 articles.

1. Palareti G, Leali N, Coccheri S et al (1996) Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on complications of oral anticoagulant therapy. Lancet 348:423–428

2. Palareti G, Manotti C, DAngelo A et al (1997) Thrombotic events during oral anticoagulant treatment: results of the inception-cohort, prospective, collaborative ISCOAT study: iSCOAT study group (Italian Study on complications of oral anticoagulant therapy). Thromb Haemost 78:1438–1443

3. Loeliger EA (1985) ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control. Thromb Haemostas 53:155–166

4. Antonucci E, Poli D, Tosetto A et al (2015) The Italian START-register on anticoagulation with focus on atrial fibrillation. PLoS One 10:e0124719

5. Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and economic impact of first-line or drug-naïve catheter ablation and delayed second-line catheter ablation for atrial fibrillation using a patient-level simulation model;Journal of Medical Economics;2024-09-10

2. Clinical predictors of recurrent strokes and bleeding in patients with atrial fibrillation receiving oral anticoagulation (20-year follow-up in the register of long-term antithrombotic therapy [REGATA-2]);Kardiologicheskii vestnik;2024

3. Over-anticoagulation by vitamin K antagonists and gender differences;International Journal of Cardiology;2022-09

4. Cost-Utility and Budget Impact Analysis of Implementing Anticoagulation Clinics and Point-of-Care Monitoring Devices in Anticoagulated Patients in Argentina;PharmacoEconomics - Open;2022-07-14

5. Expert Recommendations on the Usage of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) from India: Current Perspective and Future Direction;Cardiology and Therapy;2022-02-08